Market Watch for Star Scientific Inc. Issued by Beacon Equity


DALLAS, March 25, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring Star Scientific Inc. (Nasdaq:CIGX). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: http://www.beaconequity.com/i/CIGX

Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity

Star Scientific Inc. (CIGX) engages in the development, implementation and licensing of its proprietary technology, which cures tobacco without substantial formation of toxins, especially nitrosamines (TSNAs). The Company intends to manufacture, sell, market and develop ultra low-TSNA dissolvable smokeless tobacco products, products designed to treat tobacco dependence and neurological conditions, including depression and other psychiatric disorders; Parkinson's and Alzheimer's diseases as well as other neurological disorders. 

In the report, the analyst notes:

"The Company's immediate focus is on the production and sale of ARIVA and STONEWALL Hard Snuff brands, its dissolvable low-TSNA smokeless tobacco products. The Company established a new subsidiary, Rock Creek, with the intent to develop botanical-based products for the treatment of tobacco dependency as well as MAO-agent products for the treatment of certain neurological and psychiatric conditions, including depression and other psychiatric diseases, and neurological conditions, including Parkinson's and Alzheimer's diseases.

"The Company has devoted a significant amount of resources on its legal struggle with RJ Reynolds; the development of its low-TSNA dissolvable smokeless tobacco products, ARIVA and STONEWALL Hard Snuff; the licensing of low-TSNA products; the development of its Rock Creek facility; and its proprietary StarCured tobacco curing process. The Company's success depends upon favorable outcomes of the above-named activities. Though revenue from licensing royalties and smokeless tobacco sales has been minimal, the Company intends to continue its efforts in these areas."

To read the entire report visit: http://www.beaconequity.com/i/CIGX

See what investors are saying about these stocks at penny stock forum.

BeaconEquity.com is one of the industry's largest small-cap report providers striving to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com

Beacon Equity Disclosure

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Beacon Equity nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.



            

Contact Data